COMMUNIQUÉS West-GlobeNewswire

-
NEXGEL Reports Record Second Quarter 2024 Revenue of $1.44 Million
14/08/2024 -
Molecular Templates, Inc. Reports Second Quarter 2024 Financial Results and Corporate Update
14/08/2024 -
Plus Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights
14/08/2024 -
Shuttle Pharma Ready to Enroll Patients in Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma
14/08/2024 -
Genelux Corporation Reports Second Quarter 2024 Financial Results and Provides General Business Updates
14/08/2024 -
Vivos Therapeutics Reports Second Quarter 2024 Financial Results and Provides Operational Update
14/08/2024 -
Turnstone Biologics Corp. Reports Second Quarter 2024 Financial Results and Provides Recent Business Highlights
14/08/2024 -
Matinas BioPharma Reports Second Quarter 2024 Financial Results and Provides a Business Update
14/08/2024 -
Seer Appoints Nicolas Roelofs to its Board of Directors
14/08/2024 -
LENZ Therapeutics Reports Second Quarter 2024 Financial Results
14/08/2024 -
STRATA Skin Sciences Reports Second Quarter 2024 Financial Results and Provides a Corporate Update
14/08/2024 -
Windtree Announces New Additions and Changes to Its Board of Directors
14/08/2024 -
Pyxis Oncology Provides Corporate Update and Reports Financial Results for Second Quarter 2024
14/08/2024 -
Fractyl Health Reports Second Quarter 2024 Financial Results and Provides Business Updates
14/08/2024 -
Actuate Therapeutics Announces Closing of Initial Public Offering
14/08/2024 -
GT Biopharma Reports Second Quarter 2024 Financial Results and Provides Corporate Update
14/08/2024 -
Longeveron® Announces Second Quarter 2024 Financial Results and Provides Business Update
14/08/2024 -
Cyclacel Pharmaceuticals Reports Second Quarter Financial Results and Provides Business Update
14/08/2024 -
Jushi Holdings Inc. Announces Option Re-Pricing Program
14/08/2024
Pages